✦ LIBER ✦

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

✍ Scribed by Winer, Eric S; Ingham, Randall R; Castillo, Jorge J

Book ID: 120499401
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 253 KB
Volume: 21
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.2012.656199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bruton's tyrosine kinase inhibitors for

Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis

✍ Whang, Jennifer A.; Chang, Betty Y. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Bruton Tyrosine Kinase Inhibitor Ibrutin

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

✍ Advani, R. H.; Buggy, J. J.; Sharman, J. P.; Smith, S. M.; Boyd, T. E.; Grant, B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 353 KB

CAL-101: a phosphatidylinositol-3-kinase

CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies

✍ Castillo, Jorge J; Furman, Michael; Winer, Eric S 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 299 KB

Nilotinib: a novel Bcr-Abl tyrosine kina

Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemias

✍ Jabbour, Elias; El Ahdab, Samih; Cortes, Jorge; Kantarjian, Hagop 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 316 KB

Structure-Based Drug Design of RN486, a

Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis

✍ Lou, Yan; Han, Xiaochun; Kuglstatter, Andreas; Kondru, Rama K.; Sweeney, Zachary 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 426 KB

Nilotinib: A New Tyrosine Kinase Inhibit

Nilotinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia

✍ Anthony Jarkowski; Richard P. Sweeney 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB